These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20001800)

  • 21. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance.
    Price-Schiavi SA; Jepson S; Li P; Arango M; Rudland PS; Yee L; Carraway KL
    Int J Cancer; 2002 Jun; 99(6):783-91. PubMed ID: 12115478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
    Senapati S; Chaturvedi P; Sharma P; Venkatraman G; Meza JL; El-Rifai W; Roy HK; Batra SK
    Br J Cancer; 2008 Sep; 99(6):949-56. PubMed ID: 18781152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
    Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
    Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling.
    Zhu Y; Zhang JJ; Peng YP; Liu X; Xie KL; Tang J; Jiang KR; Gao WT; Tian L; Zhang K; Xu ZK; Miao Y
    Oncotarget; 2017 Feb; 8(6):10385-10399. PubMed ID: 28060749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?
    Kakkassery V; Winterhalter S; Nick AC; Joachim SC; Joussen AM; Kociok N
    Curr Eye Res; 2017 Oct; 42(10):1382-1388. PubMed ID: 28622066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells.
    Zhu X; Price-Schiavi SA; Carraway KL
    Oncogene; 2000 Sep; 19(38):4354-61. PubMed ID: 10980611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis.
    Liberelle M; Magnez R; Thuru X; Bencheikh Y; Ravez S; Quenon C; Drucbert AS; Foulon C; Melnyk P; Van Seuningen I; Lebègue N
    Sci Rep; 2019 Nov; 9(1):16678. PubMed ID: 31723153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor.
    Komatsu M; Jepson S; Arango ME; Carothers Carraway CA; Carraway KL
    Oncogene; 2001 Jan; 20(4):461-70. PubMed ID: 11313977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
    Yokoyama A; Shi BH; Kawai T; Konishi H; Andoh R; Tachikawa H; Ihara S; Fukui Y
    Biochem Biophys Res Commun; 2007 Mar; 355(1):200-3. PubMed ID: 17292332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
    Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
    Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.
    Mariette C; Perrais M; Leteurtre E; Jonckheere N; Hémon B; Pigny P; Batra S; Aubert JP; Triboulet JP; Van Seuningen I
    Biochem J; 2004 Feb; 377(Pt 3):701-8. PubMed ID: 14583090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta.
    Lomako J; Lomako WM; Carothers Carraway CA; Carraway KL
    J Cell Physiol; 2010 Apr; 223(1):209-14. PubMed ID: 20054827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
    Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
    Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFbeta regulation of membrane mucin Muc4 via proteosome degradation.
    Lomako WM; Lomako J; Soto P; Carraway CA; Carraway KL
    J Cell Biochem; 2009 Jul; 107(4):797-802. PubMed ID: 19388004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
    Chaturvedi P; Singh AP; Chakraborty S; Chauhan SC; Bafna S; Meza JL; Singh PK; Hollingsworth MA; Mehta PP; Batra SK
    Cancer Res; 2008 Apr; 68(7):2065-70. PubMed ID: 18381409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.
    Joshi S; Cruz E; Rachagani S; Guha S; Brand RE; Ponnusamy MP; Kumar S; Batra SK
    Mol Oncol; 2016 Aug; 10(7):1063-77. PubMed ID: 27185392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.